Literature DB >> 36037436

Mitral Regurgitation and Serum N-Terminal Pro-Brain Natriuretic Peptide Levels in Children: A Modification of Adult Criteria.

Elif Erolu1, Figen Akalin2.   

Abstract

Mitral regurgitation can result from congenital heart disease, rheumatic valve disease, or other congenital malformations of the mitral valve. Faulty valves require surgical repair or replacement. However, echocardiographic and biochemical parameters that inform surgical decision-making for adults may not be appropriate for children. To investigate whether adult parameters can be used in children, we correlated echocardiographic parameters with serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in children with chronic mitral regurgitation. Our sample comprised 45 patients and 38 healthy children. M-mode measurements, left atrial and left ventricular volumes, and Doppler and tissue Doppler echocardiograms were collected. We graded mitral regurgitation according to European Association of Echocardiography recommendations and indexed effective regurgitant area, vena contracta, and regurgitant volume to body surface area. Patients were grouped by regurgitation severity (mild vs moderate or severe) and left ventricular end-systolic dimension (normal vs enlarged). The NT-proBNP level was higher in patients than in controls (P=0.003), higher in patients with moderate or severe regurgitation (P=0.02), and higher in patients with an enlarged left ventricle (P=0.003). Serum NT-proBNP levels correlated with effective regurgitant area (r=0.47; P=0.002), vena contracta width (r=0.46; P=0.003), regurgitant volume (r=0.32; P=0.04), left ventricular end-systolic diameter (r=0.58; P <0.001), and left atrial diameter (r=0.62; P <0.001). An NT-proBNP value of 66 pg/mL differentiated the mild regurgitation group from the moderate or severe regurgitation group. Our results correlating NT-proBNP and echocardiographic parameters indexed to body surface area indicate that these adult criteria can be used in children to grade mitral regurgitation and inform surgical decision-making.
© 2022 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Adolescent; child; echocardiography, Doppler; heart ventricles/diagnostic imaging; mitral valve insufficiency/diagnostic imaging, natriuretic peptide, brain/blood; pediatrics/standards

Mesh:

Substances:

Year:  2022        PMID: 36037436      PMCID: PMC9427059          DOI: 10.14503/THIJ-20-7285

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  23 in total

1.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-08-01       Impact factor: 24.094

2.  Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals.

Authors:  Steven J Soldin; Offie P Soldin; Alanna J Boyajian; Madeline S Taskier
Journal:  Clin Chim Acta       Date:  2005-12-19       Impact factor: 3.786

3.  Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.

Authors:  Mihael Potocki; Johannes Mair; Michael Weber; Christian Hamm; Thilo Burkard; Renate Hiemetzberger; Klaus Peters; Nikolaus Jander; Thomas A Cron; Niklaus Hess; Andreas Hoffmann; Helmut Gekeler; Christa Gohlke-Bärwolf; Peter Buser; Christian Mueller
Journal:  Am J Cardiol       Date:  2009-06-18       Impact factor: 2.778

4.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

5.  [Epidemiology of mitral valve disease in pediatrics: a Lebanese study].

Authors:  Ghassan Chehab; Issam El-Rassi; Imad Chokor; Chawke Hammoud; Zakhia Saliba
Journal:  J Med Liban       Date:  2011 Oct-Dec

6.  PISA method for assessment of mitral regurgitation in children.

Authors:  Osman Başpinar; Sevim Karaaslan; Bülent Oran
Journal:  Anadolu Kardiyol Derg       Date:  2005-09

7.  Validation of the proximal isovelocity surface area method for assessing mitral regurgitation in children.

Authors:  H Aotsuka; K Tobita; H Hamada; M Uchishiba; S Tateno; K Matsuo; T Fujiwara; K Niwa
Journal:  Pediatr Cardiol       Date:  1996 Nov-Dec       Impact factor: 1.655

8.  Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.

Authors:  Chun-Wang Lin; Xiang-Lin Zeng; Jin-Feng Zhang; Xiu-Hui Meng
Journal:  J Card Fail       Date:  2013-12-19       Impact factor: 5.712

9.  Indications for intervention in asymptomatic children with chronic mitral regurgitation.

Authors:  Joyce T Johnson; Aaron W Eckhauser; Nelangi M Pinto; Hsin-Yi Weng; L LuAnn Minich; Lloyd Y Tani
Journal:  Pediatr Cardiol       Date:  2014-10-11       Impact factor: 1.655

10.  Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease.

Authors:  Yoko Kunii; Masahiro Kamada; Shinichi Ohtsuki; Tohru Araki; Kohichi Kataoka; Misao Kageyama; Naomi Nakagawa; Yoshiki Seino
Journal:  Acta Med Okayama       Date:  2003-08       Impact factor: 0.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.